Blog
Month: March 2022

Gene therapies – simpler doesn’t mean simple

Blog

Cell and gene therapies are produced and delivered via the most complex workflows in the history of medicine. Among those workflows, though, there’s a range…

Vineti secures new patent from USPTO for individualized medicine platform

Blog

SAN FRANCISCO, March ##, 2022 (GLOBE NEWSWIRE) – Vineti, Inc., the provider of the leading digital platform of record for cell and gene therapies, today…

Cell and gene therapies – new treatments, new value

Blog

At the recent Gene Therapy for Rare Disorders conference in Boston, I had the opportunity to discuss thoughts on value with an audience dedicated to…

Vineti Appoints Ann Klein as Chief Executive Officer

Blog

Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the successful completion of its Service Organization Control (SOC®)…